Evidence map›Paper›PMID 41751388›Full record

ArticleBiomedicines2026

Identification and Functional Validation of PTH2R as a Therapeutic Target in Lung Adenocarcinoma.

Changmin Liu, Yongfu Wang, Wei Liu, Yizhen Yuan, Yajing Xue, Pengzhuo Tao, Dan Sun, Te Kian Keong, Shilin Chen, Chi Song

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Changmin LiuSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Yongfu WangSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Wei LiuSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Yizhen YuanSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Yajing XueSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Pengzhuo TaoSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Dan SunInstitute of Herbgenomics, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.ORCID 0000-0003-1637-6902
Te Kian KeongMk Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman Jalan Sungai Long, Bandar Sungai Long, Kajang 43000, Selangor, Malaysia.
Shilin ChenSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Chi SongSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.ORCID 0000-0003-3904-963X

Funding

The National Key Research and Development Program No. 2024YFD2100700
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bioinformaticsfamily B1 GPCRslung adenocarcinomamelatoninPTH2R

Identifiers

PMID41751388
PMCPMC12937737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.